Breast and Ovarian Cancer [NEW TOPIC PAGE]

Main|Search|PHGKB

Last Posted: Jun-07-2019 1PM

Last Posted: May 30, 2019

---

• Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
  Kemp Zoe et al. JAMA network open 2019 May 2(5) e194428
• Cancer genetic health communication in families tested for hereditary breast/ovarian cancer risk: a qualitative investigation of impact on children's genetic health literacy and psychosocial adjustment.
  Tercyak Kenneth P et al. Translational behavioral medicine 2019 May 9(3) 493-503
• Developing a culturally targeted video to enhance the use of genetic counseling in Latina women at increased risk for hereditary breast and ovarian cancer.
  Hurtado-de-Mendoza Alejandra et al. Journal of community genetics 2019 May
• Epithelial ovarian cancer risk: a review of the current genetic landscape.
  Flaum Nicola et al. Clinical genetics 2019 May
• Accuracy in risk understanding among BRCA1/2-mutation carriers.
  Speiser Dorothee et al. Patient education and counseling 2019 May
• Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer.
  Nicolussi Arianna et al. PeerJ 2019 7e6661
• Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process.
  McGee Jacob et al. Journal of oncology 2019 20196029097
• Trends in BRCA testing and socioeconomic deprivation.
  Martin Antony P et al. European journal of human genetics : EJHG 2019 May
• BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.
  Elezaby Mai et al. Radiology 2019 Apr 181814
• Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan.
  Nomura Hidetaka et al. International journal of clinical oncology 2019 May

more